Elicio Therapeutics, Inc.
NASDAQ:ELTXBiotechnology
Healthcare
$2.70 -18.90%
-$0.89 today
- Market cap
- $51.48M
- Beta
- 1.14
- P/E (TTM)
- -1.7
- EPS (TTM)
- -$2.21
52W Low $2.66High $16.00
Volume 0.41M
Average 0.34M
Balance Sheet
Inspect the capital base behind the business.
Assets
$25.86M
FY 2025 · Annual
-8.2% YoYLiabilities
$24.23M
FY 2025 · Annual
-38.7% YoYEquity
$1.64M
FY 2025 · Annual
Balance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 88.76M | 7.8M | 12.89M | 17.62M | 18.56M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 806K | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 379K | 36K | 895K | 1.28M | 73K |
| Total Current Assets | 91.25M | 10.72M | 16.35M | 20.69M | 19.31M |
| Property, Plant & Equipment (Net) | 4.44M | 8.5M | 7.28M | 6.19M | 5.08M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 723K | 617K | 0 | 696K | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 106K | 2.83M | 3.52M | 600K | 1.47M |
| Total Non-current Assets | 5.27M | 11.95M | 10.8M | 7.49M | 6.55M |
| Total Assets | 96.51M | 22.66M | 27.15M | 28.18M | 25.86M |
| Account Payables | 4.71M | 2.81M | 4.37M | 1.04M | 672K |
| Short-term Debt | 952K | 692K | 0 | 901K | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 2.3M | 1.44M | 0 | 1.17M | 0 |
| Other Current Liabilities | 2.06M | 444K | 2.57M | 2.31M | 2.53M |
| Total Current Liabilities | 11.3M | 6.87M | 9.76M | 11.52M | 8.11M |
| Long-term Debt | 0 | 0 | 0 | 20.03M | 9.41M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 92K | 11K | 2.83M | 2.62M |
| Total Non-current Liabilities | 3.71M | 6.88M | 6.02M | 27.97M | 16.12M |
| Total Liabilities | 15.01M | 13.75M | 15.77M | 39.49M | 24.23M |
| Common Stock | 300K | 3K | 96K | 110K | 178K |
| Retained Earnings | (215.14M) | (107.01M) | (142.2M) | (194.1M) | (233.67M) |
| Accumulated OCI | (103K) | 0 | (197K) | (175K) | (127K) |
| Other Stockholders Equity | 226.01M | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 81.51M | 8.92M | 11.37M | (11.31M) | 1.64M |
| Total Debt | 4.66M | 7.48M | 6.92M | 26.04M | 14.51M |
| Net Debt | (84.09M) | (316K) | (5.98M) | 8.42M | (4.05M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $14.9M |
| Other Current | $1.3M |
| Total Current Assets | $16.2M |
| PP&E (Net) | $4.8M |
| Other Non-current | $1.7M |
| Total Non-current Assets | $6.5M |
| Total Assets | $22.7M |
Analysis
Selected assets total $22.7M for Latest. The largest visible component is Cash & Equivalents at $14.9M, about 65.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | |
| 8-K | Current report | Aug 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Jul 17, 2026 | |
| 4 | Statement of changes in beneficial ownership | Jul 17, 2026 | |
| 4 | Statement of changes in beneficial ownership | Jul 17, 2026 |
How much cash does ELTX have?
Elicio Therapeutics, Inc. (ELTX) reported $18.56M in cash and equivalents in fiscal 2025.
How much debt does ELTX carry?
Elicio Therapeutics, Inc. (ELTX) reported $14.51M of total debt, with net debt of -$4.05M.
Continue the stock analysis
Jump to another research area for this company.